
NeurologyLive® Brain Games: February 22, 2026
Key Takeaways
- A Sunday quiz format delivers three expert-written questions designed to assess neurology knowledge across clinical and historical domains.
- Core subject areas repeatedly include dementia/Alzheimer disease, epilepsy, headache, movement disorders, multiple sclerosis, neuromuscular disease, sleep disorders, and cerebrovascular pathology.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is Dravet syndrome treatment paradigm!
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions includes the theme of the Diagnosing parasomnias.
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email:
Which antiseizure medication should generally be avoided in patients with Dravet syndrome due to potential seizure exacerbation related to underlying SCN1A dysfunction?
Which of the following therapies demonstrated significant seizure reduction in a randomized controlled trial and is approved as adjunctive therapy for seizures associated with Dravet syndrome?
Which of the following best reflects the current understanding of cannabidiol’s mechanism in Dravet syndrome?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?














